Assistant Professor, Medicine, University of Pittsburgh School of Medicine
Infectious Disease
Dr. Yohei Doi, MD
|
|
Give Review
Yohei works in the field of Infectious Disease. He went to medical school at Nagoya University- School of Medicine. Yohei Doi is a published physician. He published 98 publications, including: 'Thrombolytic therapy for acute myocardial infarction in rural Japan. The Kochi Acute Myocardial Infarction (KAMI) Study Group.' Yohei is registered with Medicare and accepts Medicare payments.
Publications
- Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae.
- Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor Combinations.
- Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.
- Fosfomycin: Resurgence of an old companion.
- Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review wit...
- Complete nucleotide sequences of blaCTX-M-harboring IncF plasmids from community-associated Escherichia coli strains in the United States.
- Screening for methicillin-resistant Staphylococcus aureus colonization using sponges.
- Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance.
- OXA-48-Producing Enterobacteriaceae Causing Bacteremia, United Arab Emirates.
- Molecular Features of Community-Associated Extended-Spectrum-β-Lactamase-Producing Escherichia coli Strains in the United States.
- Engineered Cationic Antimicrobial Peptides (eCAPs) to Overcome Multidrug Resistance by ESKAPE Pathogens.
- Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system.
- KPC-producing Klebsiella pneumoniae that harbor AAC(6')-Ib exhibit intermediate level amikacin resistance.
- Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens.
- Complete Sequence of a Conjugative IncN Plasmid Harboring blaKPC-2, blaSHV-12 and qnrS1 from an Escherichia coli Sequence Type 648 Strain.
- Faropenem Disks for Screening of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae.
- Klebsiella pneumoniae ST147 Co-Producing NDM-7 Carbapenemase and RmtF 16S Ribosomal RNA Methyltransferase in Minnesota.
- Escherichia coli Sequence Type 354 Coproducing CMY-2 Cephalosporinase and RmtE 16S rRNA Methyltransferase.
- Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii.
- Molecular Epidemiology of KPC-Producing Escherichia coli: Occurrence of ST131-fimH30 Subclone Harboring pKpQIL-Like IncFIIk Plasmid.
- Epidemiology and Clinical Outcomes of Patients with Carbapenem-Resistant Klebsiella pneumoniae Bacteriuria.
- Klebsiella pneumoniae ST11 Producing RmtG 16S Ribosomal RNA Methyltransferase in Miami, Florida.
- Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside modifying enzymes, which exert varying effects on plazomicin and other agents.
- Escherichia coli sequence type 131: epidemiology and challenges in treatment.
- Safety and Efficacy of Long-Term Outpatient Ertapenem Therapy.
- Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
- In vitro Responses of Acinetobacter baumannii to Two- and Three-drug Combinations Following Exposure to Colistin and Doripenem.
- Epidemiology and Molecular Characterization of Bacteremia Due To Carbapenem-Resistant Klebsiella pneumoniae in Transplant Recipients.
- Aerosolization of Acinetobacter baumannii in a trauma ICU*.
- Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of co...
- Acinetobacter baumannii: Association between Environmental Contamination of Patient Rooms and Occupant Status.
- Novel 16S Ribosomal RNA Methyltransferase RmtH Produced by Klebsiella pneumoniae Associated with War-Related Trauma.
- Community-associated extended-spectrum ?-lactamase-producing Escherichia coli infection in the United States.
- Natural history of multidrug-resistant Acinetobacter baumannii carriage in intensive care units.
- Features of Infections Due to Klebsiella pneumoniae Carbapenemase (KPC)-Producing Escherichia coli: Emergence of Sequence Type (ST) 131.
- Thrombolytic therapy for acute myocardial infarction in rural Japan. The Kochi Acute Myocardial Infarction (KAMI) Study Group.
- Exercise-induced prominent U waves as a marker of significant narrowing of the left circumflex or right coronary artery.
- Escherichia coli producing CMY-2 β-lactamase in retail chicken, Pittsburgh, Pennsylvania, USA.
- Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection.
- Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States.
- Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.
- Extended-Spectrum AmpC in Acinetobacter baumannii; ADC-56 Confers Resistance to Cefepime.
- Sequence type ST405 Escherichia coli isolate producing QepA1, CTX-M-15, and RmtB from Detroit, Michigan.
- PME-1, an extended-spectrum ?-lactamase identified in Pseudomonas aeruginosa.
- High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination te...
- Characterisation of clinical and food animal Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase belonging to ST410 phylogroup A.
- Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role...
- Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
- Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania.
- Screening for Acinetobacter baumannii colonization by use of sponges.
- Economic impact of Acinetobacter baumannii infection in the intensive care unit.
- CTX-M-35 extended-spectrum beta-lactamase conferring ceftazidime resistance in Citrobacter koseri.
- CTX-M as the predominant extended-spectrum beta-lactamases among Enterobacteriaceae in Manila, Philippines.
- Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.
- Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient.
- CTX-M-2-producing Salmonella Typhimurium isolated from pediatric patients and poultry in Brazil.
- Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania.
- Faecal carriage of CTX-M-15-producing Klebsiella pneumoniae in patients with acute gastroenteritis.
- Extensively drug-resistant Acinetobacter baumannii.
- Klebsiella pneumoniae Carbapenemase-producing Enterobacteriaceae, Northeast Florida.
- Structure of AmpC beta-lactamase (AmpCD) from an Escherichia coli clinical isolate with a tripeptide deletion (Gly286-Ser287-Asp288) in the H10 helix.
- Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase.
- Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli.
- Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.
- Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid compound.
- Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
- Genetic environment of 16S rRNA methylase gene rmtD.
- Nomenclature of plasmid-mediated 16S rRNA methylases responsible for panaminoglycoside resistance.
- Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
- High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India.
- Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
- 16S ribosomal RNA methylase RmtD produced by Klebsiella pneumoniae in Brazil.
- Community-acquired extended-spectrum beta-lactamase producers, United States.
- Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
- A step closer to extreme drug resistance (XDR) in gram-negative bacilli.
- Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
- High prevalence of metallo-beta-lactamase and 16S rRNA methylase coproduction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil.
- 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides.
- Detection of plasmid-mediated class C beta-lactamases.
- KPC type beta-lactamase, rural Pennsylvania.
- Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.
- Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae.
- PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan.
- Novel plasmid-mediated 16S rRNA methylase, RmtC, found in a proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides.
- Global spread of multiple aminoglycoside resistance genes.
- Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
- Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.
- Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
- Spread of novel aminoglycoside resistance gene aac(6')-Iad among Acinetobacter clinical isolates in Japan.
- Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates.
- Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
- Escherichia coli producing CTX-M-2 beta-lactamase in cattle, Japan.
- Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides.
- Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa.
- PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron.
- A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.
- A novel apoptosis-inducing protein from Helicobacter pylori.
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Great West Healthcare-Cigna PPO
- CoreSource
- First Health (Coventry Health Care) PPO
- Highmark Blue Cross Blue Shield
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- UPMC PPO
- UPMC Health Plan
Education
-
University of Pittsburgh Medical Center -
St Luke's-Roosevelt Hospital Center -
Nagoya University- School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316149719 |
| Last Name Of The Provider | DOI |
| First Name Of The Provider | YOHEI |
| View All |
Similar Doctors
|
|
Dr. Ross D. Cranston, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond E. Pontzer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert R. Muder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark M. Hofstetter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee H. Harrison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew G. Sahud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preeti Kaur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Minh-Hong Nguyen, MD |
|
|
Dr. Nicole D. Wheeler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon A. Riddler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary C. McEllistrem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fernanda P. Silveira, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel G. McClung, MD |
|
|
Dr. Sarah K. McBeth, MD |
|
|
Dr. Amandeep Kaur, MD |
|
|
Adeel A. Butt, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rangolee S. Arora, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil V. Bhat, MD
This Doctor is OpenDoctor Recommended.
|